Compare
Orion Bliss Corp. vs Longevity Health Holdings, Inc. vs Park Ha Biological Technology Co., Ltd. vs Meiwu Technology Co Ltd
| Latest fiscal year | Orion Bliss Corp. ORIB | Longevity Health Holdings, Inc. XAGE | Park Ha Biological Technology Co., Ltd. BYAH | Meiwu Technology Co Ltd WNW |
|---|---|---|---|---|
| Year ended | 2026-04-30 | 2025-12-31 | 2025-10-31 | 2025-12-31 |
| Revenue | $12.0K | $1.91M | $2.52M | $7.08M |
| Revenue growth (YoY) | -53.9% | n/m | +6.0% | n/m |
| Gross margin | n/a | 57.2% | 94.4% | 10.1% |
| Operating margin | -341.1% | -371.6% | -956.5% | -124.1% |
| Net margin | -341.1% | -361.0% | -965.0% | -262.5% |
| Net income | -$40.9K | -$6.91M | -$24.36M | -$18.59M |
| EPS (Diluted) | $0.00 | -$4.83 | -$41.38 | -$0.82 |
| Operating cash flow | -$31.8K | -$3.33M | $85.9K | $9.04M |
| Free cash flow | n/a | -$3.34M | -$3.0K | n/a |
| Cash & equivalents | $0 | $706.7K | $3.79M | $17.88M |
| Total assets | $37.0K | $2.37M | $5.95M | $50.73M |
| Total liabilities | n/a | $8.23M | $1.96M | $1.34M |
| Shareholders' equity | -$144.8K | -$5.87M | $3.99M | $49.39M |
| Return on year-end equity | n/a | n/a | -609.9% | -37.6% |
| Shares outstanding | 3.04M | 1.78M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Orion Bliss Corp. | Longevity Health Holdings, Inc. | Park Ha Biological Technology Co., Ltd. | Meiwu Technology Co Ltd |
|---|---|---|---|---|
| Latest | $12.0K Ended 2026-04-30 | $1.91M Ended 2025-12-31 | $2.52M Ended 2025-10-31 | $7.08M Ended 2025-12-31 |
| 1 year earlier | $26.0K Ended 2025-04-30 | $50.3K Ended 2024-12-31 | $2.38M Ended 2024-10-31 | $158.5K Ended 2024-12-31 |
| 2 years earlier | $500 Ended 2024-04-30 | $0 Ended 2023-12-31 | $2.46M Ended 2023-10-31 | $10.98M Ended 2023-12-31 |
| 3 years earlier | $600 Ended 2023-04-30 | n/a | $1.92M Ended 2022-10-31 | $10.98M Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2022-04-30 | n/a | n/a | $12.26M Ended 2021-12-31 |